Prothena reports Q2 EPS $1.22 vs. ($1.03) last year
PremiumThe FlyProthena reports Q2 EPS $1.22 vs. ($1.03) last year
1M ago
PRTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PRTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Prothena announces Bristol Myers Squibb obtained exclusive PRX019 license
Premium
The Fly
Prothena announces Bristol Myers Squibb obtained exclusive PRX019 license
4M ago
PRTA Earnings this Week: How Will it Perform?
PremiumPre-EarningsPRTA Earnings this Week: How Will it Perform?
5M ago
Prothena announces review on birtamimab mechanism
Premium
The Fly
Prothena announces review on birtamimab mechanism
5M ago
Prothena names David Ford chief people officer
Premium
The Fly
Prothena names David Ford chief people officer
7M ago
Prothena price target raised to $85 from $81 at JMP Securities
PremiumThe FlyProthena price target raised to $85 from $81 at JMP Securities
7M ago
Prothena reports Q4 EPS ($1.26), consensus ($1.22)
Premium
The Fly
Prothena reports Q4 EPS ($1.26), consensus ($1.22)
7M ago
Prothena Corporation (PRTA) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Prothena Corporation (PRTA) Q4 Earnings Cheat Sheet
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100